Drug Type Fecal microbiota transplantation |
Synonyms |
Target- |
Mechanism Bacteria replacements, Microbiome modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Caelus Pharmaceuticals BVStartup |
Active Organization Caelus Pharmaceuticals BVStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cachexia | Preclinical | - | Caelus Pharmaceuticals BVStartup | 13 Apr 2022 |